Ontario Centre of Innovation
VC Fund
Toronto, Canada
Ontario Centre of Innovation is a VC fund in Toronto focused on Health Care and Medical. Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
- Total investments:
- 52
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Ontario Centre of Innovation invests in
Stages Ontario Centre of Innovation invests in
Countries Ontario Centre of Innovation invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $366k–$3.2M
- Grant
- $7.3k–$110k
- Pre-Seed
- $146k–$2.5M
Investment Focus
Industry
- Health Care 13 (25%)
- Medical 7 (13%)
- Software 7 (13%)
- Biotechnology 6 (12%)
- Medical Device 6 (12%)
Stage
- Seed 22 (42%)
- Pre-Seed 10 (19%)
- Grant 8 (15%)
- Series A 2 (4%)
- Convertible Note 1 (2%)
Country
- Canada 39 (75%)
- United States 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Claudia Krywiak
President & CEO
|
President & CEO | Total investments: 11 | Find email | |
Tanya Dunn
Executive Assistant to the President & CEO
|
Executive Assistant to the President & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
mDETECT Inc
|
Mdetect develops DNA-methylation-based liquid biopsy technology designed to detect and manage metastatic breast cancer. This technology allows for the rapid and accurate determination of tumor burden in patients, providing oncologists with critical insights into therapy response. | $365.7K / Seed / May 11, 2026 | |
Esphera SynBio
|
Esphera SynBio operates as a biotechnology company. Esphera SynBio provides practitioners of synthetic biology for the treatment and prevention of disease. | $365.7K / Seed / May 11, 2026 | |
Synakis
|
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous. | $1.9M / Seed / May 11, 2026 | |
|
Synakis
|
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and in vivo, low-swelling, stable, and optically transparent with a refractive index and density similar to those of the native vitreous. | $1.9M / Seed / May 11, 2026 | |
Script Runner
|
Script Runner provides AI-powered prescription delivery and logistics software for pharmacies and healthcare providers. The platform enables pharmacies and hospitals to manage last-mile prescription delivery using in-house drivers, Script Runner’s driver network, or integrated services such as Uber Direct. It supports route planning, ordertracking, and drone-based recurring deliveries for medications within defined distances. The software includes tools for secure payment collection at the door or online, along with data security and storage aligned with industry compliance standards. Script Runner also offers virtual care and virtual prescribing capabilities for minor ailments bundled with delivery, helping providers coordinate clinical services with logistics in a single system. | $365.7K / Seed / May 11, 2026 | |
Synmedix
|
Synmedix's mission is to provide new therapies that avoid the pitfalls of the past by avoiding resistance, addressing clinical gaps, and delivering solid economics in an equitable manner. It is a biotechnology company. For inquiries, email, telephone numbers, and physical addresses are available on their website. | $365.7K / Seed / May 11, 2026 | |
myStoria
|
Mystoria offers a digital platform for fertility support, empowering users with tools and knowledge for reproductive health. | $365.7K / Seed / May 11, 2026 | |
|
myStoria
|
Mystoria offers a digital platform for fertility support, empowering users with tools and knowledge for reproductive health. | $365.7K / Seed / May 11, 2026 | |
Kare Chemical Technologies
|
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes. | $365.7K / Pre-Seed / May 11, 2026 | |
NodeAI Diagnostics
|
NodeAI Diagnostics develops AI-driven tools to improve lung cancer staging by enhancing ultrasound analysis during biopsies. | $365.7K / Seed / May 11, 2026 | |
| See all 52 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ontario Centre of Innovation invest in?
Ontario Centre of Innovation invests primarily in Health Care, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 52 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Ontario Centre of Innovation's check size?
Ontario Centre of Innovation typically joins rounds of $366k–$3.2M at Seed, $7.3k–$110k at Grant and $146k–$2.5M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Ontario Centre of Innovation participates in.
How do I contact Ontario Centre of Innovation?
Public channels for Ontario Centre of Innovation include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ontario Centre of Innovation?
The team at Ontario Centre of Innovation includes Claudia Krywiak (President & CEO) and Tanya Dunn (Executive Assistant to the President & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
